Lixisenatide In pregnant rats receiving twice daily subcutaneous doses of 2.5, 35, or 500 mcg/kg during organogenesis (gestation day 6 to 17), fetuses were present with visceral closure defects (e.g., microphthalmia, bilateral anophthalmia, diaphragmatic hernia) and stunted growth
Unfortunately, this was not enough to stop Lily from using them regularly and perhaps more worryingly, despite knowing they're illegal, she also admits to selling nasal sprays and promoting them on social media
Requiring a higher BMI threshold such as 32 creates unnecessary delays in care and forces patients to worsen before qualifying for treatment
As the dosage is carefully escalated in a research protocol (moving from 2 mg to 4 mg, 6 mg, and so on), the compound's effects become much more pronounced